<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00832897</url>
  </required_header>
  <id_info>
    <org_study_id>1915/07</org_study_id>
    <nct_id>NCT00832897</nct_id>
  </id_info>
  <brief_title>Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Corneal Ring</brief_title>
  <official_title>&quot;Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Intrastromal Corneal Ring for Treatment of Keratoconus and Others Irregulars Astigmatisms.&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to postpone the corneal transplantation in keratoconus and
      promote the stiffness of the cornea across the riboflavin-UVA corneal collagen crosslinking ,
      and after, corneal ring surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Keratoconus is a progressive disease where cornea is thin and has a higher curvature.In early
      conditions, it may be corrected by glasses or contact lens.When these possibilities are not
      more possibles, it may be corrected by corneal ring surgery ore corneal transplantation
      depending your degree.

      In this study, the patients with a degree of keratoconus on I or II, will be submitted to
      corneal collagen crosslinking and then a corneal ring surgery.

      The corneal collagen crosslinking promote the stiffness of the cornea across the
      riboflavin-UVA irradiation, avoid the progression of the keratoconus.After three months of
      crosslinking, these patients will be submitted a corneal ring surgery.

      These patients will be allowed by two years and various exams will realized them.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Refractive data, visual acuity, topography patterns, pachymetry measurements.</measure>
    <time_frame>Two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior segment tomography data, corneal biomechanics, impression cytology.</measure>
    <time_frame>Two years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>Eyedrop</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Crosslinking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will be submitted to corneal collagen crosslinking, by use riboflavin eyedrop with UVA light.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Corneal collagen crosslinking</intervention_name>
    <description>The patients will be submitted to corneal collagen crosslinking, that consists:
Instillation of riboflavin eyedrop in the cornea for thirty minutes, and after, the patient will stay under the Crosslinking equipment, for more thirty minutes, also receiving riboflavin eyedrop.</description>
    <arm_group_label>Eyedrop</arm_group_label>
    <arm_group_label>Crosslinking</arm_group_label>
    <other_name>Keratoconus.</other_name>
    <other_name>Corneal collagen crosslinking.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with keratoconus

          -  Patients that aren't using contact lenses

          -  Pachymetry more than 400Um

          -  Best visual acuity less or equal 20/30

        Exclusion Criteria:

          -  Ocular surgeries before

          -  Other eye diseases

          -  Corneal curvature more than 65 dioptres
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adimara C Renesto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mauro S Campos, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marta F Sartori, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>04038-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Mencucci R, Mazzotta C, Rossi F, Ponchietti C, Pini R, Baiocchi S, Caporossi A, Menchini U. Riboflavin and ultraviolet A collagen crosslinking: in vivo thermographic analysis of the corneal surface. J Cataract Refract Surg. 2007 Jun;33(6):1005-8.</citation>
    <PMID>17531694</PMID>
  </reference>
  <reference>
    <citation>Coskunseven E, Kymionis GD, Tsiklis NS, Atun S, Arslan E, Jankov MR, Pallikaris IG. One-year results of intrastromal corneal ring segment implantation (KeraRing) using femtosecond laser in patients with keratoconus. Am J Ophthalmol. 2008 May;145(5):775-9. doi: 10.1016/j.ajo.2007.12.022. Epub 2008 Mar 4.</citation>
    <PMID>18291344</PMID>
  </reference>
  <results_reference>
    <citation>Wollensak G, Spoerl E. Collagen crosslinking of human and porcine sclera. J Cataract Refract Surg. 2004 Mar;30(3):689-95.</citation>
    <PMID>15050269</PMID>
  </results_reference>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2009</study_first_submitted>
  <study_first_submitted_qc>January 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2009</study_first_posted>
  <last_update_submitted>January 6, 2011</last_update_submitted>
  <last_update_submitted_qc>January 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2011</last_update_posted>
  <responsible_party>
    <name_title>Federal University of São Paulo</name_title>
    <organization>Federal University of São Paulo</organization>
  </responsible_party>
  <keyword>Keratoconus</keyword>
  <keyword>riboflavin</keyword>
  <keyword>cornea</keyword>
  <keyword>crosslinking</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Riboflavin</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

